Proanthocyanin content in cranberry CE medicinal products

Phytotherapy Research

Volumn 28, Issue 11, 2014, Pages 1612-1614

  Chrubasik Hausmann, Sigrun ^a   Vlachojannis, Christian ^a   Zimmermann, Benno F ^b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c Institut Prof Dr Georg Kurz GmbH   (Germany)

Author keywords

CE medicinal products; Cranberry; Proanthocyanins; Recurrent urinary tract infections

Indexed keywords

4 DIMETHYLAMINO CINNAMIC ALDEHYDE; CINNAMALDEHYDE; COLORING AGENT; PLANT MEDICINAL PRODUCT; PROANTHOCYANIN; UNCLASSIFIED DRUG; MICROCAPSULE; PLANT EXTRACT; PROANTHOCYANIDIN;

ARTICLE; CRANBERRY; DRUG CAPSULE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUALITY CONTROL; TABLET; CHEMISTRY; EUROPEAN UNION; FRUIT; MICROCAPSULE; PHOTOMETRY; PHYTOTHERAPY; STANDARDS;

VACCINIUM MACROCARPON;

CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EUROPEAN UNION; FRUIT; PHOTOMETRY; PHYTOTHERAPY; PLANT EXTRACTS; PROANTHOCYANIDINS; VACCINIUM MACROCARPON;

EID: 84915745542     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5172     Document Type: Article

References (12)

1. Beerepoot MA, ter Riet G, Nys S, et al. 2011. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med 171: 1270-1278.
2. Bianco L, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M. 2012. Pilot randomized controlled dosing study of cranberry capsules for reduction of bacteriuria plus pyuria in female nursing home residents. J AmGeriatr Soc 60: 1180-1181.
3. Chrubasik-Hausmann S, Vlachojannis C, Zimmermann B. 2014. Pomgranate juice and prostate cancer: Importance of the characterisation of the active principle. Phytotherapy Res. DOI: 10.1002/ptr.5181
4. Davidson E, Zimmermann BF, Jungfer E, Chrubasik-Hausmann S. 2013. Prevention of Urinary Tract Infections with Vaccinium Products. Phytother Res.
5. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, LM. 2005. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 66: 2281-2291.
6. Jepson RG,Williams G, Craig JC. 2012. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 10:CD001321.
7. Jungfer E, Zimmermann BF, Ruttkat A, Galensa R. 2012. Comparing procyanidins in selected Vaccinium species by UHPLC-MS (2) with regard to authenticity and health effects. J Agric Food Chem 60: 9688-9696.
8. Lavigne JP, Bourg G, Combescure C, Botto H, Sotto A. 2008. In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clin Microbiol Infect 14: 350-355.
9. NN. Verordnung (EU) Nr. 175/2014 der Kommission vom 25.2.2014. Amtsblatt der Europäischen Union: L56/7.
10. Prior RL, Fan E, Ji H, et al. 2010. Multi-laboratory validation of a standard method for quantifying proanthocyanidins in cranberry powders. J Sci Food Agric 90: 1473-1478.
11. Sengupta K, Alluri KV, Golakoti T, et al. 2011. A randomized, double blind, controlled, dose dependent clinical trial to evaluate the efficacy of a proanthocyanidin standardized whole cranberry (Vaccinium macrocarpon) powder on infections of the urinary tract. Curr Bioact Compd 7: 39-46.
12. Website 1993. http://eur-lex.europa.eu/LexUriServ/LexUriServ. do?uri=CONSLEG:1993L0042:20071011:EN:PDF